Launched Cytowel (Cytarabine For Injection)

Launched Cytarabine in 2019 by the brand name Cytowel 100mg/ml, 500mg/5ml, 1gm/10ml strength

Approved indications of Cytowel

• Indicated alone or in combination for indication of remission and/or maintenance in patients with acute myeloid leukaemia, acute non-lymphoblastic leukaemia, acute lymphoblastic leukaemias, acute lymphocytic leukaemia, erythroleukaemia, blast crises of chronic myeloid leukaemia, diffuse histiocytic lymphomas (non-Hodgkin’s lymphomas of high maligmamcy), meningeal leukaemia and meningeal neoplasms.